OUR TEAM

Jessica is a behavioral scientist focused on implementation of and engagement with digital health platforms. Her work focuses on personalization of technology-based platforms, use of factorial experimental designs to understand and improve engagement, and applying mixed-methods approaches to guide implementation of digital health platforms in routine medical settings. She also has a program of research focused on use of digital phenotyping to inform precision medicine across a range of brain health concerns including bipolar disorder, major depressive disorder and migraine.

Jessica received her PhD in Clinical Psychology from the University of Rhode Island. Prior to her role at BWH, she completed a specialized fellowship in implementation science at the Boston VA’s Center for Healthcare Organization and Implementation Research (CHOIR). Dr. Lipschitz is active in initiatives to form stronger partnerships between academia and industry and in reviewing journal articles in the digital health space.

Sofia graduated from Brown University with a BA in Psychology and Gender and Sexuality Studies. She is currently involved in all studies at the Lipschitz Lab. Her interests center on developing accessible mental health interventions for mood and anxiety disorders, as well as exploring mental health disparities in marginalized communities. As an undergraduate, she completed an honors thesis examining deficiencies in contextual processing among individuals experiencing symptoms of PTSD. Sofia plans to apply to a PhD program in Clinical Psychology in the near future.

Chelsea graduated summa cum laude from Dartmouth College with a BA in Psychology and a minor in English. She was involved in all studies at the Lipschitz Lab, with a specific interest in the development of accessible interventions. As an undergraduate, she designed and conducted a survey and interview study of pregnant cannabis users to identify risk factors for continued cannabis use during pregnancy, culminating in a peer-reviewed first-author paper. She was previously lead coordinator of an R01-funded clinical trial investigating whether CBD reduces neuroinflammation in chronic pain patients. Chelsea is now pursuing her Doctorate in Clinical Psychology at the University of Vermont, and is still a collaborator on several of our projects.

Catherine (Cate) received a BS in Psychology and a minor in Chemistry from Duke University. When pursuing her MS in Medical Sciences from Boston University, she completed her graduate thesis with the Lipschitz Lab on longitudinal predictors of episodic migraines in women, while also collaborating on all studies. Her clinical interests include identifying predictive factors for migraines and/or mood disorders, specifically in women and children. Cate is currently a medical student at Florida State University and hopes to pursue a career as a psychiatrist. 

Rachel received her BS in Neuroscience from Boston College. She was involved in all studies at the Lipschitz Lab, with a specific interest in longitudinal clinical outcomes across a variety of brain-related illnesses. As an undergraduate, she spent several years as a cognitive neuroscience research assistant examining age-related effects of cognition through behavioral and fMRI research approaches. Rachel is now pursuing her Doctorate in Clinical Psychology at Stanford University, and is still a collaborator on several of our projects.